Stem cell abnormalities in esophagus may lead to Barrett's esophagus
the ONA take:
According to new findings published in the journal Cell Reports, researchers at the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania, have found that the esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
The findings of the study could help in better understanding the causes of esophageal cancer and Barrett's esophagus, as well as lead to the development of new treatment options. The researchers knew that cells in the inner layers of the esophagus divide twice weekly to produce cells that ultimately become the specialized cells of the lining of the esophagus. The dying cells slough off into the gastrointestinal tract.
This study determined that there is a subpopulation of stem cells in the deeper layers of the esophagus, disproving the belief that all the cells in the deeper layers are the same.
Stem cells are more likely to rest rather than divide, so it was believed that there were no stem cells in the esophagus due to the regular division of cells. The researchers found that these stem cells divide slowly whereas the other cells in the deeper layers divide regularly. Future studies must be conducted to determine if esophageal stem cell abnormalities lead to Barrett's esophagus.
The esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. The findings could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett's esophagus.
According to the American Cancer Society, more than 18,000 people will be diagnosed with esophageal cancer in the U.S. in 2014 and almost 15,500 people will die from it. In Barrett's esophagus, the lining of the esophagus changes for unknown reasons to resemble that of the intestine, though gastro-esophageal reflux disease or GERD is a risk factor for its development.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|